Literature DB >> 12464787

SPECT using 99mTc-DTPA for the assessment of disease activity in Graves' ophthalmopathy: a comparison with the results from MRI.

L Galuska1, A Leovey, Z Szucs-Farkas, I Garai, J Szabo, J Varga, E V Nagy.   

Abstract

Currently available methods for the estimation of disease activity in the orbits of patients with Graves' ophthalmopathy (GO) have the disadvantages of being either expensive or time consuming. The aim of this study was to develop a quick, reliable method using Tc labelled diethylenetriaminepentaacetic acid (DTPA) and four-headed single photon emission computed tomography (SPECT) for this purpose. The theoretical basis of the method is that the high capillarization and oedema in the orbit may be reflected on Tc-DTPA images in GO. SPECT data of 28 orbits of 14 patients with GO were compared with magnetic resonance imaging (MRI) T2 relaxation time scores. Based on the number of 'active' muscles with T2 relaxation times of more than 70 ms in a given orbit, an MRI score of 0 (no active muscle) to 4 (all rectus muscles active) was assigned to the orbit. With MRI, 18 orbits were inactive, and 10 were active. Thirty minutes after the intravenous administration of 7 MBq.kg Tc-DTPA, 128 projections were acquired by a four-headed SPECT. On the sum of six transaxial slices containing the entire bulbar region of the skull, a triangle-like region of interest (ROI) was drawn (OR ROI). This ROI was 'slipped' to the right temporal region of the brain as reference site (B ROI). The count ratios of OR/B were calculated and compared to MRI score values. In the group of 18 inactive orbits (an MRI score of zero on both sides), in the transaxial plane, the mean OR/B value was 6.4+/-1.17, and in the group of 10 active orbits (an MRI score of 1-3) 8.30+/-2.08, the difference being significant (P <0.05). Tc-DTPA orbital SPECT is a promising method for the estimation of disease activity in the orbits of patients with Graves' ophthalmopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464787     DOI: 10.1097/00006231-200212000-00010

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

1.  Differences in SPET analysis of thyroid-associated orbitopathy.

Authors:  Lázló Galuska; József Varga; Zsolt Szücs-Farkas; Endre V Nagy; Kenneth D Burman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-06       Impact factor: 9.236

2.  99mTc-DTPA SPECT/CT provided guide on triamcinolone therapy in Graves' ophthalmopathy patients.

Authors:  Dan Liu; Xueliang Xu; Sha Wang; Chengzhi Jiang; Xinhui Li; Jia Tan; Zhihong Deng
Journal:  Int Ophthalmol       Date:  2019-12-02       Impact factor: 2.031

3.  Monitoring and Predicting Treatment Response of Extraocular Muscles in Grave's Orbitopathy by 99mTc-DTPA SPECT/CT.

Authors:  Chengzhi Jiang; Zilong Deng; Jin Huang; Haoyu Deng; Jia Tan; Xinhui Li; Min Zhao
Journal:  Front Med (Lausanne)       Date:  2021-12-16

4.  The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves' orbitopathy.

Authors:  Ru-Xuan Zhao; Ting-Ting Shi; Sha Luo; Yun-Fu Liu; Zhong Xin; Jin-Kui Yang
Journal:  Endocr Connect       Date:  2022-02-09       Impact factor: 3.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.